Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-17), HOB Biotech Group's 3-1 Month Momentum % is -13.73%.
The industry rank for HOB Biotech Group's 3-1 Month Momentum % or its related term are showing as below:
SHSE:688656's 3-1 Month Momentum % is ranked worse than 58.98% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 0.12
vs SHSE:688656: -13.73
HOB Biotech Group (SHSE:688656) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
HOB Biotech Group 3-1 Month Momentum % Related Terms
SHSE:688656 vs ABT, SYK, MDT: 3-1 Month Momentum % Comparison
For the Medical Devices subindustry, HOB Biotech Group's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HOB Biotech Group 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HOB Biotech Group's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where HOB Biotech Group's 3-1 Month Momentum % falls into.
HOB Biotech Group (SHSE:688656) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HOB Biotech Group (SHSE:688656) has a 3-1 Month Momentum % of -13.73% as of Sep. 17, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on HOB Biotech Group and its competitors. According to the industry distribution chart, HOB Biotech Group ranks #496 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 59%.
Is HOB Biotech Group's 3-1 Month Momentum % too high?
HOB Biotech Group's current 3-1 Month Momentum % is -13.73%. Based on the distribution chart, HOB Biotech Group ranks #496 out of 841 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, HOB Biotech Group has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HOB Biotech Group's 3-1 Month Momentum % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, HOB Biotech Group ranks #496 out of 841 companies for 3-1 Month Momentum %. This places HOB Biotech Group in the lower half of its industry. The industry median 3-1 Month Momentum % is 0.12. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
The median 3-1 Month Momentum % among Medical Devices & Instruments companies is 0.12, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on HOB Biotech Group and its competitors. For the Medical Devices & Instruments industry, the median 3-1 Month Momentum % is 0.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HOB Biotech Group's current 3-1 Month Momentum % is -13.73%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HOB Biotech Group stock overvalued right now?
Based on GuruFocus' analysis, HOB Biotech Group (SHSE:688656) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥95.96, compared to a current price of ¥112.28 — trading 17% above its estimated fair value. The current 3-1 Month Momentum % is -13.73%. HOB Biotech Group's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For HOB Biotech Group (SHSE:688656), the current 3-1 Month Momentum % is -13.73% as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HOB Biotech Group (SHSE:688656) Overvalued in 2026?
Based on GuruFocus' analysis, HOB Biotech Group stock appears to be overvalued.
The current stock price of ¥112.28 is trading 17% above its estimated GF Value™ of ¥95.96.
GuruFocus considers HOB Biotech Group to be Modestly Overvalued.
Key valuation signals for SHSE:688656:
3-1 Month Momentum %: -13.73%
GF Value™: ¥95.96 vs. price of ¥112.28 (17% above fair value)
No single metric tells the full story. See the SHSE:688656 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.
82GF Score
Get the complete analysis for SHSE:688656
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688656 has been successfully added to your 
